0 Ask Beta Account

Evaluation of a new ovulatory stimulating agent: clomiphene citrate (clomid)

No Authors Listed

JAMA, 206(3), 635-636

DOI 10.1001/jama.1968.03150030091021 PMID 5695585

Abstract

Clomiphene citrate, in selected patients, is an effective agent for the treatment of infertility due to anovulation. An adequate laboratory and physical evaluation of each individual patient is essential for proper use of the drug. The major adverse reactions encountered are ovarian enlargements and cysts; in most patients, these conditions regress spontaneously after withdrawal of the drug.

Topics

Infertility > Ovulation Induction > Clomiphene CitrateReproductive Endocrinology > Pharmacology > Ovulatory AgentsGeneral OB/GYN > Drug Evaluation > Adverse Effects
clomiphene citrate clomid ovulation induction anovulation, clomiphene citrate treatment anovulatory infertility 1960s, ovulatory stimulating agent clomid evaluation, clomiphene citrate adverse reactions ovarian enlargement cysts, anovulation drug therapy clomiphene clinical evaluation, ovarian hyperstimulation clomiphene citrate side effects, clomid infertility treatment patient selection criteria, clomiphene citrate early clinical trials effectiveness, medical management anovulatory infertility pharmacologic ovulation induction, clomid ovarian cyst regression spontaneous withdrawal
PMID 5695585 5695585 DOI 10.1001/jama.1968.03150030091021 10.1001/jama.1968.03150030091021

Cite this article

No Authors Listed (1968). Evaluation of a new ovulatory stimulating agent: clomiphene citrate (clomid). *JAMA*, *206*(3), 635-636. https://doi.org/10.1001/jama.1968.03150030091021

Keywords

Clomiphene/administration & Dosage/adverse Effects, Female, Humans, Infertility, Female/drug Therapy, Ovarian Cysts/chemically Induced, Ovarian Diseases/chemically Induced, Pregnancy, Clomiphene

Related articles

Clomiphene citrate in the management of anovulation: a review of mechanisms, outcomes, and clinical challenges
Tadesse TM, 2026 Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology

OBJECTIVE: To review the mechanism of action, epidemiology, clinical efficacy, factors influencing treatment outcomes, and limitations of clomiphene citrate (CC). METHODS: A systematic literature sea...

Infertility > Ovulation Induction > Clomiphene CitratePCOS > Treatment > Ovulation InductionReproductive Endocrinology > Anovulation > Pharmacological Management

Use of clomiphene citrate in women
American Society for Reproductive Medicine, 2003 Fertility and Sterility
Infertility > Ovulation Induction > Clomiphene CitrateInfertility > Medical Treatment > Practice GuidelinesPCOS > Treatment > Ovulation Induction

A prospective randomized trial comparing clomiphene citrate with tamoxifen citrate for ovulation induction
Boostanfar R et al., 2001 Fertility and Sterility

OBJECTIVE: To compare the rates of ovulation and pregnancy after tamoxifen citrate (TMX) or clomiphene citrate (CC) among anovulatory women with infertility. DESIGN: Prospective randomized trial. SE...

Infertility > Ovulation Induction > Clomiphene CitrateInfertility > Ovulation Induction > Tamoxifen ComparisonResearch Methodology > Randomized Controlled Trial > Ovulation Induction